Current advances in radiotherapy for breast cancer require knowledge of the anatomy of irradiated areas to minimize geographic miss and spare organs at risk. This study aimed at defining a contouring approach for supraclavicular (SC) and infraclavicular (IC) nodes after mastectomy or conservative surgery in patients with breast cancer.
Methods and Study Design
In 15 patients, SC and IC nodes were contoured on computed tomography slices according to Madu et al and Dijkema et al. After analyzing relapse sites, as reported by Reed et al, our approach was defined. The 3 methods were compared in all patients, quantifying differences in contours by percentage overlap (PO).
Results
In our approach, SC node delineation is similar to Madu et al in the ventral and medial landmarks, but includes the lateral SC nodes described by Dijkema et al. The lateral landmarks are the scalenus anterior and medius muscle lateral border and the clavicle. Dorsal boundaries are the scalenus anterior and medius muscle ventral and lateral surfaces and the subclavian artery ventral border. In IC node delineation, major differences emerged in cranial and dorsal limits which, in our approach, are the pectoralis minor muscle upper edge and the subclavian axillary artery ventral side. Our mean and median volumes and POs were between the other 2 methods.
Conclusions
This study contributes to standardizing draining node contouring, so as to reduce variability and minimize geographic miss.
ClarkeM., CollinsR., DarbyS.; Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet.2005; 366(9503): 2087–2106.
2.
DarbyS., McGaleP., CorreaC.; Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials. Lancet.2011; 378(9804): 1707–1716.
3.
OvergaardM., HansenP.S., OvergaardJ.Postoperative radiotherapy in high-risk pre-menopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b trial. N Engl J Med.1997; 337(14): 949–955.
4.
OvergaardM., JensenM.B., OvergaardJ.Postoperative radiotherapy in high-risk post-menopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet.1999; 353(9165): 1641–1648.
5.
RagazJ., OlivottoI.A., SpinelliJ.J.Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst.2005; 97(15): 116–126.
6.
Sautter-BihlM.L., SedlmayerF., BudachW.One life saved by four prevented recurrences? Update of the Early Breast Cancer Trialists confirms: postoperative radiotherapy improves survival after breast conserving surgery. Strahlenther Onkol.2012; 188(6): 461–463.
7.
Van de SteeneJ., SoeteG., StormeG.Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiother Oncol.2000; 55(3): 263–272.
8.
WhelanT.J., JulianJ., WrightJ., JadadA.R., LevineM.L.Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol.2000; 18(6): 1220–1229.
9.
AristeiC., LeonardiC., StracciF.Risk factors for relapse after conservative treatment in T1-T2 breast cancer with one to three positive axillary nodes: results of an observational study. Ann Oncol.2011; 22(4): 842–847.
10.
BiancosinoA., BremerM., KarstensJ.H., BiancosinoC., MeyerA.Postoperative periclavicular radiotherapy in breast cancer patients with 1-3 positive axillary nodes. Outcome and morbidity. Strahlenther Onkol.2012; 188(5): 417–423.
11.
ChengJ.C., ChenC.M., LiuM.C.Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy. Int J Radiat Oncol Biol Phys.2002; 52(4): 980–988.
12.
FodorJ., PolgárC., MajorT., NémethG.Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation. Strahlenther Onkol.2003; 179(3): 197–202.
13.
GalperS., RechtA., SilverB.Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys.1999; 45(5): 1157–1166.
14.
MacDonaldS.M., Abi-RaadR.F., Alm El-DinM.A.Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy. Int J Radiat Oncol Biol Phys.2009; 75(5): 1297–1303.
15.
TruongP.T., OlivottoI.A., KaderH.A., PanadesM., SpeersC.H., BertheletE.Selecting breast cancer patients with T1-T2 tumors and one to three axillary positive nodes at high postmastec-tomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys.2005; 61(5): 1337–1347.
16.
TruongP.T., JonesS.O., KaderH.A.Patients with T1 to T2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys.2009; 73(2): 357–364.
17.
WhelanT.J., OlivottoI., AckermanJ.NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol.2011; 29(suppl): abstract LBA1003.
18.
NCCN (National Comprehensive Cancer Network).Clinical Practice Guidelines in Oncology™. NCCN Guidelines for Treatment of Cancer by site. Breast Cancer. Version 2.2015. Available at: http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed March 11, 2015.
19.
KurtzJ., for the EUSOMA Working Party. EUSOMA Guidelines. The curative role of radiotherapy in the treatment of operable breast cancer. Eur J Cancer.2002; 38(15): 1961–1974.
20.
RechtA., EdgeS.B., SolinL.J.Postmastectomy radiotherapy: guidelines of the American Society of Clinical Oncology. J Clin Oncol.2001; 19(5): 1539–1569.
21.
Sautter-BihlM.L., SouchonR., BudachW.DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease. Strahlenther Onkol.2008; 184(7): 347–353.
22.
Sautter-BihlM.L., SedlmayerF., BudachW.Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). DEGRO practical guidelines: radiotherapy of breast cancer III: radiotherapy of the lymphatic pathways. Strahlenther Onkol.2014; 190(4): 342–351.
23.
TruongP.T., OlivottoI.A., WhelanT.J., LevineM.; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 16: locoregional postmastectomy radiotherapy. CMAJ.2004; 170(8): 1263–1273.
24.
FotinaI., Lütgendorf-CaucigC., StockM., PötterR., GeorgD.Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy. Strahlenther Onkol.2012; 188(2): 160–167.
25.
HurkmansC.W., BorgerJ.H., PietersB.R., RussellN.S., JansenE.P., MijnheerB.J.Variability in target volume delineation on CT scans of the breast. Int J Radiat Oncol Biol Phys.2001; 50(5): 1366–1372.
26.
LandisD.M., LuoW., SongJ.Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. Int J Radiat Oncol Biol Phys.2007; 67(5): 1299–1308.
27.
StruikmansH., Wárlám-RodenhuisC., StamT.Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiation. Radiother Oncol.2005; 76(3): 293–299.
28.
van MourikA.M., ElhkuizenP.H.M., MinkemaD., DuppenJ.C., Dutch Young Boost Study Group, van Vliet-VroegindeweijC.Multiinsti-tutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines. Radiother Oncol.2010; 94(3): 286–291.
29.
Castro PenaP., KirovaY.M., CampanaF.Anatomical, clinical and radiological delineation of target volumes in breast cancer radiotherapy planning: individual variability, questions and answers. Br J Radiol.2009; 82(979): 595–599.
30.
LiX.A., TaiA., ArthurD.W.; Radiation Therapy Oncology Group Multi-Institutional and Multiobserver Study. Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG multi-institutional and multiobserver study. Int J Radiat Oncol Biol Phys.2009; 73(3): 944–951.
31.
DijkemaI.M., HofmanP., RaaijmakersC.P., LagendijkJ.J., BattermannJ.J., HillenB.Loco-regional conformal radiotherapy of the breast: delineation of the regional lymph node clinical target volumes in treatment position. Radiother Oncol.2004; 71(3): 287–295.
32.
KlagesH.T., SzafinskiF., MakoskiH.B.Variation in “supraclavicular” lymph node depth is partly determined by treatment position. Strahlenther Onkol.2000; 176(7): 315–318.
33.
MaduC.N., QuintD.J., NormolleD.P., MarshR.B., WangE.J., PierceL.J.Definition of the supraclavicular and infraclavicular nodes: implications for three-dimensional CT-based conformal radiation therapy. Radiology.2001; 221(2): 333–339.
34.
ReedV.K., CavalcantiJ.L., StromE.A.Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer. Int J Radiat Oncol Biol Phys.2008; 71(2): 435–440.
35.
KirovaY.M., Castro PenaP., DendaleR.Simplified rules of everyday delineation of lymph nodes areas for breast cancer radiotherapy. Br J Radiol.2010; 83(992): 683–686.
NielsenM.H., BergM., PedersenA.N.; Danish Breast Cancer Cooperative Group Radiotherapy Committee. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol.2013; 52(4): 703–710.
38.
OffersenB.V., BoersmaL.J., KirkoveC.ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol.2015; 114(1): 3–10.
39.
BentelG.C., MarksL.B., HardenberghP.H., ProsnitzL.R.Variability of the depth of supraclavicular and axillary lymph nodes in patients with breast cancer: is a posterior axillary boost field necessary?Int J Radiat Oncol Biol Phys.2000; 47(3): 755–758.
40.
JagsiR., MoranJ., MarshR., MasiK., GriffithK.A., PierceL.J.Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer. Int J Radiat Oncol Biol Phys.2010; 78(5): 1594–1603.
41.
SethiR.A., NoH.S., JozsefG., KoJ.P., FormentiS.C.Comparison of three dimensional versus intensity modulated radiotherapy techniques to treat breast and axillary level III and supraclavicular nodes in a prone versus supine position. Radiother Oncol.2012; 102(1): 74–81.
